Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news.

As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.

Twenty years ago, drug discovery ran on a simple script of screening compounds and hoping for a hit. This exclusive ebook, ...

Alzheimer’s disease often overlaps with other causes of cognitive decline. A new proteomics project aims to untangle that ...

Traditional animal models remain an important part of preclinical research, but species differences can limit translation of ...

From AI agents to cell therapy to Alzheimer’s drug pipelines, this issue follows the same problem across three fields:what it takes to turn something that works once into something that works at scale ...